AIM: To evaluate the incidence of surgical site infections and bacteremias occurring within 30 days from insertion of partially implanted central venous catheters. PATIENTS AND METHODS: Four hundred eighteen devices positioned in children with cancer or undergoing bone marrow transplant were followed prospectively. RESULTS: During a follow-up of 12,394 catheter-days, a total of 13 infectious episodes were documented, with an overall incidence of 3.1% and 1.05 episodes/1,000 catheter-days. Coagulase-negative staphylococci represented the causative pathogens of all episodes. Overall, surgical wound infections occurred in 1.4% of all catheters, with a rate of 0.48/1,000 catheter-days, while isolated bacteremias were observed in 1.7% of all inserted devices, with a rate of 0.57/1,000 catheter-days. CONCLUSIONS: Infections are rare events within 30 days from insertion of partially implanted central venous catheters and coagulase-negative staphylococci represent the most frequently isolated cause of these complications. (c) 2006 Wiley-Liss, Inc.
AIM: To evaluate the incidence of surgical site infections and bacteremias occurring within 30 days from insertion of partially implanted central venous catheters. PATIENTS AND METHODS: Four hundred eighteen devices positioned in children with cancer or undergoing bone marrow transplant were followed prospectively. RESULTS: During a follow-up of 12,394 catheter-days, a total of 13 infectious episodes were documented, with an overall incidence of 3.1% and 1.05 episodes/1,000 catheter-days. Coagulase-negative staphylococci represented the causative pathogens of all episodes. Overall, surgical wound infections occurred in 1.4% of all catheters, with a rate of 0.48/1,000 catheter-days, while isolated bacteremias were observed in 1.7% of all inserted devices, with a rate of 0.57/1,000 catheter-days. CONCLUSIONS:Infections are rare events within 30 days from insertion of partially implanted central venous catheters and coagulase-negative staphylococci represent the most frequently isolated cause of these complications. (c) 2006 Wiley-Liss, Inc.
Authors: S Avanzini; E Guida; M Conte; F Faranda; P Buffa; C Granata; E Castagnola; G Fratino; L Mameli; A Michelazzi; A Pini-Prato; G Mattioli; A C Molinari; E Lanino; V Jasonni Journal: Pediatr Surg Int Date: 2010-06-20 Impact factor: 1.827
Authors: Arne Simon; Roland A Ammann; Udo Bode; Gudrun Fleischhack; Hans-Martin Wenchel; Dorothee Schwamborn; Chara Gravou; Paul-Gerhardt Schlegel; Stefan Rutkowski; Claudia Dannenberg; Dieter Körholz; Hans Jürgen Laws; Michael H Kramer Journal: BMC Infect Dis Date: 2008-05-23 Impact factor: 3.090
Authors: Ayush Gupta; Arti Kapil; S K Kabra; Rakesh Lodha; Seema Sood; Benu Dhawan; Bimal K Das; V Sreenivas Journal: Indian J Med Res Date: 2013-12 Impact factor: 2.375